Balangas, Jessa .

HRN: 26-33-15  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/06/2025
CEFUROXIME 500MG (TAB)
07/06/2025
07/12/2025
PO
500mg
Bid
Nsvd Wbc 23.2
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Prophylaxis    Compliance to guidelines: